Skip to main content
Premium Trial:

Request an Annual Quote

BCW Index Up 5.3 Percent for First Quarter

The BCW Index rose 5.31 percent for the first quarter of 2006, with shares of 11 of the 16 firms in the Index increasing during the period. For the period from Jan. 3 to Apr. 4, the Index outgained the Nasdaq, which rose 4.53 percent for the same period; the Nasdaq Biotech Index, which gained 3.69 percent; and the Dow Jones Industrial Average, which increased 3.29 percent.

Thermo Electron led all gainers with a 22.06-percent rise in its shares. Other strong performers for the quarter included Qiagen, which gained 20.68 percent; Molecular Devices, which rose 19.23 percent; and Bruker BioSciences and Agilent, which both gained more than 13 percent.

The five firms to lose ground during the first quarter were Beckman Coulter, Bio-Rad Laboratories, General Electric, Harvard Bioscience, and PerkinElmer. Harvard Bio had the largest decline by far, falling 15.22 percent for the quarter.

File Attachments
The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.